Bacallao MRA, Madrid MC, Mañalich CR, Gutiérrez GF, Badell MA

Language: Spanish
References: 36
Page: 456-467
PDF size: 160.82 Kb.

ABSTRACT

Introduction: the recurrence of urinary lithiasis is a health problem needing the implementation of preventive strategies, thus knowing the frequency of the different renal metabolic disorders is essential.
Objectives: To identify the most common metabolic disorders in urinary lithiasic disease and their relationship with patient characteristics.
Methods: an analytical, cross-sectional study was conducted in 3655 adult patients with urolithiasis. A renal metabolic study was conducted at the Institute of Nephrology from 2003 to 2009. The analytical determinations were performed by spectrophotometric technique according to the standards of service. All information is processed using SPSS version 15.0. The technique of frequency distribution analysis was used. Relationships between variables were identified by the test of independence.
Results: The main metabolic disorders found were: hyperuricemia (48.2%), hypercalciuria (45.1%), and urinary tract infection (16.2 %). Hypercalciuria and hyperuricosuria were less frequent in subjects older than 42 years (p= 0.01). Hypercalciuria, hyperoxaluria and hyperuricosuria were more frequent in men (p= 0.00), while hypocitraturia was more frequent in women (p= 0.04). Hyperuricosuria was found more frequently in overweight and obese patients (p= 0.00), and hyperoxaluria was more frequent among overweight subjects (p= 0.01).
Conclusions: In patients with renal lithiasis the most common metabolic disorders are hyperuricemia, hypercalciuria, and urinary tract infection. All subjects younger than 43 years suffered hypercalciuria and hyperuricosuria. Men have higher frequency of hypercalciuria, hyperuricosuria and hyperoxaluria. Women have higher frequency of hypocitraturia. The frequency of submission of hyperoxaluria, hyperuricosuria and hypocitraturia is related to the nutritional status of these subjects.

REFERENCES

1. Domingos F, Serra A. História da litíase urinária os primórdios da nefrologia. Rev Port Nefrol Hipert. 2004;18(3):143-53.

2. Abdel-Halim RE. Urolithiasis in adults. Clinical and biochemical aspects. Saudi Med J. 2005;26:705-13.

3. Amato M, Lusini ML, Nelli F. Epidemiology of nephrolithiasis today. Urol Int. 2004;72(Suppl 1):1-5.

4. Amaro C, Goldberg J, Amaro J, Padovani C. Metabolic assessment in patients with urinary lithiasis. Int Braz Urol. 2005;31:29-33.

5. Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol. 2010;25:831-41.

6. Bushinsky DA, Coe FL, Moe OW. Nephrolithiasis. En: Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, editores. The Kidney. 9 ed. Philadelphia: Elsevier Health Sciences; 2011. p. 1455-507.

7. Reyes L, Mirabal M, Mañalich R, Almaguer M. Estudio comparativo del comportamiento clínico epidemiológico de la urolitiasis en dos poblaciones diferentes de Cuba. Rev Port Nefrol Hipert. 2004;18(3):155-65.

8. Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34:287-93.

9. Jiménez Acosta S, Díaz ME, Barroso I, Bonet M, Cabrera A, Wong I. Estado nutricional de la población cubana adulta. Rev Esp Nutr Comunitaria. 2005;11(1):18-26.

10. Pérez-Oliva J, Pérez R, Herrera R, Almaguer M, Brisquet E. Terapia renal de reemplazo dialítico en Cuba: tendencia durante los últimos 10 años. Rev Hab Cienc Méd. 2012;11(3):424-33.

11. Spivacow FR, Negri AL, del Valle EE, Calvino I, Zanchetta JR. Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol. 2009;42:471-5.

12. Del Valle E, Spivacow R, Zanchetta JR. Alteraciones metabólicas en 2,612 pacientes con litiasis renal. Rev Med Argent. 1999;59:417-22.

13. Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int. 2008;73:489-96.

14. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350(11):1093-103.

15. Ljubojevic M, Herak-Kramberger CM, Hagos Y. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol. 2004;287:124.

16. Deshmukh S, Khan Z. Evaluation of urinary abnormalities in nephrolithiasis patients from Marathwada region. Ind J Clinic Biochemistry. 2006;21:177-80.

17. Yagisawa T, Hayashi T, Yoshida A, Kobayashi C, Okuda H, Ishikawa N, Toma H. Comparison of metabolic risk factors in patients with recurrent urolithiasis stratified according to age and gender. Eur Urol. 2000;38:297-301.

18. Kok DJ, Papapoulos SE, Bijvoet OLM. Crystal agglomeration is a major element in calcium oxalate urinary stone formation. Kidney Int. 1990;37:51-6.

19. Ossandon Salas E, Storme Cabrera O, Ledesma R, Marchant González F, Palma C, Recadal Gutraldes P. Resultados del estudio metabólico en 54 pacientes con urolitiasis de alto riesgo de recurrencia. Actas Urológicas Españolas. 2009;33(4):429-32.

20. Arrabal-PoloI MA, Arrabal-Martin M, Garrido-Gómez J. Calcium renal lithiasis: metabolic diagnosis and medical treatment. Sao Paulo Med J. 2013;131(1):46-53.

21. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab. 2006;91:3144.

22. Myamoto K, Ito M, Tatsumi S, et al. New aspects of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrology. 2007;27:503.

23. Tenenhouse HS, Murer H. Disorders of renal tubular phosphate transport. J Am Soc Nephrol. 2003;14:240.

24. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med. 2004;164:885.

25. Villanueva Jorge S, Medina Escobedo M, Arcos Díaz A, Martin Soberanis G. Excreción de oxalatos y citratos en pacientes con litiasis urinaria. Bioquimía. 2007;32(4):134-40.

26. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59:270.

27. Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18:2198.

28. Okamoto N, Aruga S, Matsuzaki S. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls. Int J Urol. 2007;14:344.

29. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis an update of a 1980 protocol. Am J Med. 1995;98:50-9.

30. Lancina Martín JA, Rodríguez Rivera J, Novás Castro S, Rodríguez Gómez I, Fernández Rosado E, Álvarez Castelo L, et al. Factores de riesgo metabólico en urolitiasis cálcica según el sexo y edad de los pacientes. Actas Urol Esp. 2002;26(2):111-20.

31. Sharma V, Murphy MS, Thind S, Nath R. Effect of sex hormone on oxalate synthesizing enzymes in weanling rats. Biochem Int. 1981;3:507-15.

32. Lemann J Jr, Pleuss JA, Worcester EM, Hornick L, Schrab D, Hovmann RG. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int. 1996;49(1):200–08.

33. Del Valle EE, Spivacow FR, Negri AL, Pinduli I, Forrester M. Metabolic diagnosis in stone formers in relation to body mass index. Urol Res. 2012;40:47-52.

34. Lieske JC. New insights regarding the interrelationship of obesity, diet, physical activity, and kidney stones. J Am Soc Nephrol. 2014 Feb;25(2):211-2.

35. Parivar F, Low RK, Stoller ML. Influence of diet on urinary stone disease. J Urol. 1996;155:432.

36. Najeeb Q, Masood I, Bhaskar N, Kaur H, Singh J, Pandey R, et al. Effect of BMI and urinary pH on urolithiasis and its composition. Saudi J Kidney Dis Transpl. 2013 Jan;24(1):60-6.